Skip to content

FTC: 1Health.io (Vitagene), DNA data privacy case

US Federal Trade Commission · decided Jun 16, 2023 · Settled

The FTC alleged the genetic testing company left DNA data unprotected, misled consumers about deletion and changed its privacy policy retroactively.

The case

Against
1Health.io Inc. (Vitagene)
Regulator
US Federal Trade Commission
Decided
Jun 16, 2023
Status
SettledOrder finalized September 2023.
Outcome
1Health must strengthen protections for genetic information and get consent before retroactive privacy policy changes.

History

1 dated entry
DateEntry
Jun 16, 2023Decision: FTC: 1Health.io (Vitagene), DNA data
WhenCase
Oct 5Status Conference tentatively in 10dnext dateIn re Consumer Vehicle Driving Data Tracking LitigationStatus Conference tentativelyActivePrivacyN.D. Ga.
Oct 6Next Case Management Conference in 11dnext dateIn re Meta Pixel Healthcare LitigationNext Case Management ConferenceActivePrivacyN.D. Cal.
Oct 14An in-person status hearing is in 19dnext dateIn re Clearview AI Consumer Privacy LitigationAn in-person status hearing isSettledPrivacyN.D. Ill.23% equity stake in Clearview AI
Apr 19, 2027Jury Trial in 7monext dateUnited States v. Cerebral (health data for ads)Jury TrialSettledPrivacyS.D. Fla.$7 million
Aug 31Filed 25d agofiledIsbell v. SunoActivePrivacyD. Mass.
Aug 21Filed 35d agofiledDutch DPA fine: Uber, automated driver deactivationDecidedPrivacyDutch Data Protection Authority (Autoriteit Persoonsgegevens)EUR 824,990,000
May 21Filed 4mo agofiledTexas AG v. Meta and WhatsApp: encryption claimsActivePrivacyTexas Attorney General
May 12Filed 4mo agofiledFlowers v. MicrosoftActivePrivacyN.D. Ill.
Caption and links

In the Matter of 1Health.io Inc.

Lawsuit updates by email

Tuesdays, only in weeks with rulings, filings or hearings in data and AI cases.

Double opt-in. Unsubscribe any time.